Decreased costs and retained QoL due to the 'PACE Steps to Success' intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial.

MLA

Wichmann, Anne B., et al. “Decreased Costs and Retained QoL Due to the ‘PACE Steps to Success’ Intervention in LTCFs: Cost-Effectiveness Analysis of a Randomized Controlled Trial.” BMC Medicine, vol. 18, no. 1, Sept. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12916-020-01720-9.

APA

Wichmann, A. B., Adang, E. M. M., Vissers, K. C. P., Szczerbińska, K., Kylänen, M., Payne, S., Gambassi, G., Onwuteaka-Philipsen, B. D., Smets, T., Van den Block, L., Deliens, L., Vernooij-Dassen, M. J. F. J., Engels, Y., on behalf of the PACE trial group, Andreasen, P., Barańska, I., Bassal, C., Moore, D. C., Finne-Soveri, H., & Froggatt, K. (2020). Decreased costs and retained QoL due to the “PACE Steps to Success” intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial. BMC Medicine, 18(1), N.PAG. https://doi.org/10.1186/s12916-020-01720-9

Chicago

Wichmann, Anne B., Eddy M. M. Adang, Kris C. P. Vissers, Katarzyna Szczerbińska, Marika Kylänen, Sheila Payne, Giovanni Gambassi, et al. 2020. “Decreased Costs and Retained QoL Due to the ‘PACE Steps to Success’ Intervention in LTCFs: Cost-Effectiveness Analysis of a Randomized Controlled Trial.” BMC Medicine 18 (1): N.PAG. doi:10.1186/s12916-020-01720-9.